Daratumumab in multiple myeloma-Reference-Cited by-同舟云学术

Daratumumab in multiple myeloma

Published:2019-04-05 Issue:14 Volume:125 Page:2364-2382
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Nooka Ajay K.¹^ORCID,Kaufman Jonathan L.¹,Hofmeister Craig C.¹,Joseph Nisha S.¹^ORCID,Heffner Thomas L.¹,Gupta Vikas A.¹,Sullivan Harold C.²,Neish Andrew S.²,Dhodapkar Madhav V.¹,Lonial Sagar¹

Affiliation:

1. Department of Hematology and Medical Oncology Winship Cancer Institute, Emory University Atlanta Georgia

2. Department of Pathology Emory University Atlanta Georgia

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32065

Reference56 articles.

1. Cancer statistics, 2017

2. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

3. Human CD38: a glycoprotein in search of a function

4. Human CD38 (ADP‐ribosyl cyclase) is a counter‐receptor of CD31, an Ig superfamily member;Deaglio S;J Immunol,1998

5. Secretion of IFN-γ, IL-6, Granulocyte-Macrophage Colony-Stimulating Factor and IL-10 Cytokines after Activation of Human Purified T Lymphocytes upon CD38 Ligation

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymphocytes in autoimmune encephalitis: Pathogenesis and therapeutic target;Neurobiology of Disease;2024-10

2. Advancements in drugs restructured with nanomedicines for multiple myeloma treatment;Science China Materials;2024-09-10

3. Efficacy and safety of daratumumab in multiresistant immune‐mediated thrombotic thrombocytopenic purpura;British Journal of Haematology;2024-09-04

4. Combined daratumumab-pomalidomide and ultra-fractionated whole breast irradiation is safe!;Reports of Practical Oncology and Radiotherapy;2024-07-22

5. Safety and feasibility analysis of rapid daratumumab infusion in Chinese patients with multiple myeloma;Cancer Medicine;2024-06